ArticleCancers2021

Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer.

Loïck Galland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.